Türkiye’de viral hepatit probleminin Karadeniz bölgesi özelinde yeniden değerlendirilmesi

Kaynakça (10)

1. Johnson PJ. The epidemiology of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1996; 8:845-9
2. Craxi A, Yurdayd›n C. From viral pathobiology to the treat- ment of hepatitis B virus infection. EASL Monothematic Conference (Istanbul, Turkey, October 6-8, 2005). J Hepatol 2006; 44:1186-95
3. Chang MH, Chen CJ, Lai HM, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336:1855-9
4. Y›ld›r›m B, Barut fi, Bulut Y, et al. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the black sea region of Turkey: a population-based study. Turk J Gas- troenterol 2009; 20:27-30
5. Mistik R, Balik I. Türkiye’de viral hepatitlerin epidemiyolojisi. Bir metaanaliz. In: Viral hepatit 98. K Kilicturgay (ed). Viral Hepatitle Savasim Dernegi Yayini, 1998; 9-40
6. Uzunalimo¤lu O, Yurdaydin C, Çetinkaya H, et al. Risk fac- tors for hepatocellular carcinoma in Turkey. Dig Dis Sci 2001; 46:1022-8
7. Gürol E, Saban C, Oral O, et al. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21:299-305
8. Gürbüz AK, Do¤alp K, Gülflen M. Hepatit C virus infeksiyonunda aile içi geçifl. Gastroenteroloji 1993; 4:405-408
9. Bennet S, Woods T, Liyanage WM, Smith DL. A simplified general method for cluster sample surveys of health in developing countries. World Health Stat Q 1991; 44:98-106
10. De¤ertekin H, Yalç›n K, Yakut M, Yurdayd›n C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int 2008; 28:494-8.